Skip to main content
. 2013 Dec 9;48(11):936–957. doi: 10.1310/hpj4811-936

Table 2.

Average changes in aPTT in renal transplant and nontransplant patients receiving heparin

Changes Transplant (n = 29) Nontransplant (n = 29)
Average aPTT, seconds 72.6 ± 43.1 78.1 ± 50.6

Average highest aPTT/patient, seconds 157.4 ± 59.8 147.3 ± 74.4

Patients with >1 supratherapeutic aPTT, % 86 69

Supratherapeutic aPTTs/patient, seconds* 2.86 (range, 0–7) 1.79 (range, 0–11)

Total aPTTs/patient, seconds* 14.1 (range, 2–52) 7.6 (range, 1–47)

Average (range) heparin duration, days 7 ± 4.5 (range, 2–25) 4.7 ± 4.5(range, 1–26)

Note: Student t test was performed for normally distributed categorical data, and Mann-Whitney was performed for non-normally distribute categorical data. To calculate percent of patients with at least one supratherapeutic aPTT, the Fisher exact probability test was performed.

*P < .05.